{"id":10800,"date":"2021-05-01T00:04:44","date_gmt":"2021-05-01T00:04:44","guid":{"rendered":"http:\/\/contenidosportal.sld.cu\/portal20142020\/?p=6519"},"modified":"2021-05-01T00:04:44","modified_gmt":"2021-05-01T00:04:44","slug":"aspectos-moleculares-relacionados-con-el-uso-del-dominio-de-union-al-receptor-del","status":"publish","type":"post","link":"https:\/\/contenidosportal.sld.cu\/portal20142020\/2021\/05\/01\/aspectos-moleculares-relacionados-con-el-uso-del-dominio-de-union-al-receptor-del\/","title":{"rendered":"Aspectos moleculares relacionados con el uso del dominio de uni\u00f3n al receptor del SARS-CoV-2 como diana de las vacunas preventivas"},"content":{"rendered":"<div class=\"imagen-node-pie\">\n\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" class=\"imagefield imagefield-field_imagen\" alt=\"\" src=\"http:\/\/contenidosportal.sld.cu\/files2014-2020\/imagen\/17\/oc1c00216_0006.jpg\" width=\"242\" height=\"305\"><\/div>\n<div class=\"item-node\">\n<p>El desarrollo de vacunas&nbsp;recombinantes COVID-19 es el resultado del progreso cient&iacute;fico realizado a una velocidad sin precedentes durante 2020. El mon&oacute;mero de glicoprote&iacute;na esp&iacute;cula recombinante, su tr&iacute;mero y su dominio de uni&oacute;n al receptor recombinante (RBD) inducen una potente respuesta de anticuerpos neutralizantes anti-RBD en animales. Existe una buena correlaci&oacute;n entre la respuesta de anticuerpos y la neutralizaci&oacute;n potente en sueros de convalecientes de COVID-19.<\/p>\n<p><a href=\"https:\/\/pubs.acs.org\/doi\/10.1021\/acscentsci.1c00216#\" target=\"_blank\" rel=\"noopener\">En esta revisi&oacute;n<\/a>, se resume con visi&oacute;n cr&iacute;tica los aspectos moleculares asociados a la interacci&oacute;n del SARS-CoV-2 RBD con su receptor en c&eacute;lulas humanas, la enzima convertidora de angiotensina 2 (ECA2), los ep&iacute;topos implicados en la actividad neutralizante, y el impacto de las mutaciones de virus de los mismos. Se analizan las tendencias recientes en las vacunas basadas en RBD, proporcionando informaci&oacute;n detallada sobre la funci&oacute;n de la presentaci&oacute;n de ant&iacute;genos y la multivalencia en la respuesta inmune de las vacunas en desarrollo.<\/p>\n<p><em>Vea el art&iacute;culo completo en: <span><span class=\"hlFld-ContribAuthor\">Valdes-Balbin Y,&nbsp;<\/span><strong> <\/strong><span class=\"hlFld-ContribAuthor\">Santana-Mederos S, <\/span><\/span><span><span class=\"hlFld-ContribAuthor\">Paquet<\/span><strong> <\/strong>F, <span class=\"hlFld-ContribAuthor\">Fernandez S, Climent Y, <\/span><\/span><span><span class=\"hlFld-ContribAuthor\">&nbsp;Chiodo F, et al. <\/span><\/span><span class=\"hlFld-Title\">Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines. <\/span><span class=\"cit-title\">ACS Cent. Sci.<\/span> <span class=\"cit-year-info\"><span>2021<\/span><\/span><span class=\"cit-volume\">.<\/span><span class=\"pub-date epub-date\"> Publication Date<\/span><span class=\"date-separator\">:<\/span><span class=\"pub-date-value\">April 19, 2021<\/span><a href=\"https:\/\/doi.org\/10.1021\/acscentsci.1c00216\" title=\"DOI URL\">. https:\/\/doi.org\/10.1021\/acscentsci.1c00216.<\/a><\/em><\/p>\n<p>***\/ Traducci&oacute;n: <a href=\"mailto:gretchen@infomed.sld.cu\">Gretchen Gonz&aacute;lez Nieto<\/a><br \/>\nServicio de traducci&oacute;n<br \/>\nCNICM-Infomed<br \/>\n29 de abril de 2021<\/p>\n<\/div>\n<div class=\"clear\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>El desarrollo de vacunas&nbsp;recombinantes COVID-19 es el resultado del progreso cient&iacute;fico realizado a una velocidad sin precedentes durante 2020. El mon&oacute;mero de glicoprote&iacute;na esp&iacute;cula recombinante, su tr&iacute;mero y su dominio de uni&oacute;n al receptor recombinante (RBD) inducen una potente respuesta de anticuerpos neutralizantes anti-RBD en animales. Existe una buena correlaci&oacute;n entre la respuesta de anticuerpos [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"close","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"class_list":["post-10800","post","type-post","status-publish","format-standard","hentry","category-anuncio"],"_links":{"self":[{"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/posts\/10800","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/comments?post=10800"}],"version-history":[{"count":0,"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/posts\/10800\/revisions"}],"wp:attachment":[{"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/media?parent=10800"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/categories?post=10800"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/contenidosportal.sld.cu\/portal20142020\/wp-json\/wp\/v2\/tags?post=10800"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}